BE868768A - Nouveaux 2-thioethers d'ergoline et leurs sulfoxydes, utiles notamment comme bloqueurs des centres adrenergiques alpha et leurs procedes de preparation - Google Patents

Nouveaux 2-thioethers d'ergoline et leurs sulfoxydes, utiles notamment comme bloqueurs des centres adrenergiques alpha et leurs procedes de preparation

Info

Publication number
BE868768A
BE868768A BE189095A BE189095A BE868768A BE 868768 A BE868768 A BE 868768A BE 189095 A BE189095 A BE 189095A BE 189095 A BE189095 A BE 189095A BE 868768 A BE868768 A BE 868768A
Authority
BE
Belgium
Prior art keywords
adrenergy
thioethers
sulfoxides
blockers
centers
Prior art date
Application number
BE189095A
Other languages
English (en)
French (fr)
Original Assignee
Simes Soc It Medicinali E Sint
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simes Soc It Medicinali E Sint filed Critical Simes Soc It Medicinali E Sint
Publication of BE868768A publication Critical patent/BE868768A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE189095A 1977-07-05 1978-07-05 Nouveaux 2-thioethers d'ergoline et leurs sulfoxydes, utiles notamment comme bloqueurs des centres adrenergiques alpha et leurs procedes de preparation BE868768A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH825577 1977-07-05

Publications (1)

Publication Number Publication Date
BE868768A true BE868768A (fr) 1978-11-03

Family

ID=4337542

Family Applications (1)

Application Number Title Priority Date Filing Date
BE189095A BE868768A (fr) 1977-07-05 1978-07-05 Nouveaux 2-thioethers d'ergoline et leurs sulfoxydes, utiles notamment comme bloqueurs des centres adrenergiques alpha et leurs procedes de preparation

Country Status (7)

Country Link
US (1) US4197299A (hu)
JP (1) JPS5414999A (hu)
BE (1) BE868768A (hu)
DE (1) DE2829471A1 (hu)
FR (1) FR2396758A1 (hu)
GB (1) GB2000772B (hu)
IT (1) IT1192260B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1193467B (it) * 1978-01-26 1988-07-08 Simes Carbammati di omolisergoli (8 beta-idrossietilergoline)
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
DE3413657A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergoline
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
US4801712A (en) * 1985-06-24 1989-01-31 Eli Lilly And Company 2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity
GB8615471D0 (en) * 1986-06-25 1986-07-30 Erba Farmitalia T-butyl ergoline derivatives
DE102007014947B4 (de) * 2007-03-23 2010-05-27 Axxonis Pharma Ag Stabilisierte wässrige Lösungen von Ergolinverbindungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1429210A (fr) * 1964-04-14 1966-02-18 Farmaceutici Italia Nouveaux dérivés de méthyl.6 et diméthyl.1.6 ergoline, substitués en position 2, et leur procédé de préparation
GB1053507A (hu) * 1964-04-14
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
NL7416120A (nl) * 1973-12-21 1975-06-24 Farmaceutici Italia Werkwijze voor het bereiden van pyrimidinoami- nomethylergolinederivaten.
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
CH619709A5 (en) * 1975-03-14 1980-10-15 Siphar Sa Process for the preparation of carbamates of 2-halogenoergolines and 2-halogenoergolenes
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov

Also Published As

Publication number Publication date
FR2396758A1 (fr) 1979-02-02
DE2829471A1 (de) 1979-02-15
GB2000772B (en) 1982-02-24
FR2396758B1 (hu) 1981-06-26
DE2829471C2 (hu) 1988-09-22
GB2000772A (en) 1979-01-17
US4197299A (en) 1980-04-08
JPS5414999A (en) 1979-02-03
JPS6225149B2 (hu) 1987-06-01
IT1192260B (it) 1988-03-31
IT7823911A0 (it) 1978-05-26

Similar Documents

Publication Publication Date Title
FR2407921B1 (fr) Nouveaux 7-oxa-bicycloheptanes et -bicycloheptenes, utiles notamment comme agents cardiovasculaires, et leur procede de preparation
FR2553420B1 (fr) Nouveaux oligodesoxynucleotides et polydesoxynucleotides utiles comme agents antiviraux
DE2966301D1 (en) Enzyme derivatives for use in the treatment of venous thrombosis, compositions containing them and their preparation
IT1177375B (it) Composizione e procedimento per inibire le incrostazioni
JPS5426147A (en) Method of producing pocket in clothes
BE866031A (fr) Nouveaux 2-(2,2-diarylalkyl)-1-azabicyclo (2,2,2)octanes, utiles notamment comme antidiarrheiques, et leur procede de preparation
SE457976B (sv) Horisontalloepande rullport
FR2348926A1 (fr) Nouveaux derives de l'adenine
GB1543839A (en) Games racquets and to methods of manufacture of same
BE868768A (fr) Nouveaux 2-thioethers d'ergoline et leurs sulfoxydes, utiles notamment comme bloqueurs des centres adrenergiques alpha et leurs procedes de preparation
PL207191A1 (pl) Sposob wytwarzania nowych w 11 pozycji podstawionych 5,11-dwuhydro-6h-pirydo/2,3-b//1,4/benzodwuazepinanow-6
JPS52133989A (en) Novel aminopiperidines and method of their preparation and medical composition thereof
MX165218B (es) Composicion mejorada de polimero spandex
BE872972A (fr) Nouveaux thiobutyramides substitues et leurs procedes d'obtention
FR2346355A1 (fr) Nouveaux amoxycillinates d'amidinopenicillanoyloxyalkyle et leurs procedes de preparation
BE862097A (fr) Nouveaux benzothiophenes, leurs procedes de preparation et leur application notamment comme hypolipemiants et hypocholesterolemiants
JPS53124607A (en) Novel preparation of aspirin included in dextrine analogue
FR2319351A1 (fr) Hydantoines et procedes d'obtention
GB8817241D0 (en) Improvements in & relating to determining characteristics of conducting objects
DK41585D0 (da) Udtrykkelse af human alfa-1-antitrypsin i gaer
PH12781A (en) Antihypertensive compositions and method of use thereof
IT1075572B (it) Colopiesteri autoestinguenti e termostabili e procedimento per ottenerli
BE877308A (fr) Sulfonyl-urees, leurs procedes de preparation et leur application en therapeutique
BE865975A (fr) Nouveaux derives de chlorophenoxy-benzene utiles notamment en therapeutique
BE863266A (fr) 2,5-dimethylbenzo (b)thieno (2,3-f)morphane, utile notamment comme analgesique, et ses intermediaires, et leur procede de preparation